|

RVU120 Clinical Trials

2 actively recruiting trials

Also known as: SEL120

Pipeline

Phase 2: 2

Top Sponsors

  • Ryvu Therapeutics SA2

Indications

  • Cancer2
  • Myelofibrosis1
  • Acute Myeloid Leukemia1

Other2 trials

RVU120 in Patients With Intermediate or High-risk, Primary or Secondary Myelofibrosis
Phase 2
Safety and Efficacy of RVU120 Combined With Venetoclax for Treatment of Relapsed/Refractory AML
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.